Caloric restriction (CR) has been described to have cardioprotective effects and improve functional outcomes in animal models and humans. Chronic ischemic heart failure (HF) is associated with reduced cardiac sympathetic innervation, dysfunctional β-adrenergic receptor signaling, and decreased cardiac inotropic reserve. We tested the effects of a long-term CR diet, started late after myocardial infarction on cardiac function, sympathetic innervation, and β-adrenergic receptor responsiveness in a rat model of postischemic HF.
D
espite improvements in diagnosis, management, and treatment, heart failure (HF) still represents one of the greatest healthcare challenges worldwide for its high morbidity, mortality, and economic impact. 1, 2 This syndrome represents the final common clinical event of numerous cardiovascular diseases, with coronary artery disease-dependent myocardial infarction (MI) being its most common cause in the Western countries. 1 Despite some improvement in HF survival, the death rate remains high, and current therapies are only able to slow disease progression. Hence, there is an urgency to identify new therapies to add to the HF therapeutic armamentarium to reduce the enormous mortality rate that this disease still poses.
Dietary interventions, including caloric restriction (CR), have been proven to counteract some cardiovascular risk factors, such as diabetes mellitus, hypertension, and obesity, that are known to promote atherosclerosis and the progression of cardiac dysfunction. [3] [4] [5] [6] [7] Indeed, preclinical and clinical studies have demonstrated that CR exerts several therapeutic effects on atherosclerosis by reducing circulating cholesterol levels, systemic inflammation, and vascular fibrosis. [8] [9] [10] Furthermore, CR has also been shown to curb the maladaptive cardiac effects of hypertension in both genetic and surgical models of the disease, reducing the development of left ventricular (LV) hypertrophy and diastolic dysfunction. [11] [12] [13] [14] [15] Importantly, the beneficial actions of CR on global metabolism are widely recognized and include a reduction of visceral fat mass, fasting insulin levels, and insulin resistance in diabetic and obese patients. 7 Furthermore, CR has been described to exert direct cardioprotective effects. 3, 12, [16] [17] [18] [19] Accordingly, intermittent fasting (IF), a specific CR regimen, protects the heart from ischemic injury, reduces cardiac remodeling, and ameliorates LV function when initiated before MI induction. 17 In the same setting (IF started before MI), this CR regimen was associated with an increase in circulating adiponectin levels and a reduction in cardiac and systemic inflammation. 20 Moreover, short-term (6-week-long) IF has been shown to improve LV remodeling and survival in a rat model of postischemic HF via proangiogenic and antiapoptotic mechanisms. 21 Interestingly, the beneficial effects of CR have been also studied in obese patients with HF at preserved ejection fraction in a randomized clinical trial, where CR combined with exercise training was able to increase peak oxygen consumption. 22 Of note, all of the aforementioned studies have shown the beneficial effects of CR on the post-MI heart only in the short term. From a clinical point of view, however, it is evident that for chronic diseases, such HF, a long-term and sustained CR regimen is potentially warranted to improve outcomes. Hence, the effects of a long-standing CR diet on cardiac function and structure in a model of ischemic HF have not been properly investigated. Thus, in the present study, we have tested the effects of a 12-month CR regimen in a rat post-MI model where CR was started after HF establishment.
METHODS
The data, analytic methods, and study materials will be made available from the corresponding authors to other researchers on request for purposes of reproducing the results or replicating the procedure. Expanded Methods are available in the Data Supplement.
Experimental Design
All animal procedures and experiments were performed in accordance with the guidelines of the Institutional Animal Care Committee of University Federico II of Naples, Italy. Twomonth-old, male Sprague-Dawley rats (n=44) were randomly assigned to different surgical groups: 34 rats underwent surgically induced MI, and 10 rats received sham operation ( Figure 1A ). Mortality rate was ≈23.5% at 4 weeks post-MI. Four weeks post-MI, a time point when cardiac dysfunction was established, HF rats underwent echocardiographic evaluation and were further randomized to a 1-year CR (IF
WHAT IS NEW?
• We investigated for the first time the effects of a long-term caloric restriction (CR) regimen in an animal model of ischemic heart failure (HF).
• CR improved cardiac inotropic reserve, as indicated by the results of the in vivo hemodynamics, and restored cardiac β 1 -adrenergic receptor plasma membrane density in a chronic HF model. • CR significantly curbed the dramatic loss in cardiac sympathetic nerve fibers in the failing hearts.
• CR reverted cardiac maladaptive remodeling in ischemic HF reducing cardiac fibrosis and increasing capillary density.
WHAT ARE THE CLINICAL IMPLICATIONS?
• For chronic diseases, such HF, there is an urgency to identify new therapies that are successful if used for a long period.
• We found that a long-term and sustained CR regimen is an effective treatment in a model of ischemic HF.
• The findings of the present study are of particular interest because dietary interventions represent a cost saving therapeutic modality, whose favorable properties seem to show effectiveness comparable to that obtained with pharmacological interventions currently used in clinical practice.
• The clinical potential of CR for a place in the HF therapeutic armamentarium awaits clinical validation in patients. Figure 1 . Long-term caloric restriction (CR) decreases body weight (BW) and accordingly heart weight (HW) in ischemic heart failure (HF). A, Overall design of the 13-mo study. B, BW changes during the study period for all groups at 0, 6, and 12 mo after the beginning of the dietary protocol. C, Representative picture of HF-normal diet (ND; right) and HF-CR rats (left) at the end of the study period (12 mo after the beginning of the dietary protocol). Measures of (D) HW and (E) HW normalized to tibia length (TL dietary regimen that consists in a complete fasting day followed by a normal feed day) or normal diet (ND, standard rat diet; Figure 1A ). Sham-operated rats followed an ND regimen throughout the study period. Thus, the final population that started the dietary protocol consisted of 3 groups: shamoperated rats fed with ND (sham; n=10), HF rats fed with ND (HF-ND; n=13), and HF rats fed with CR dietary regimen (HF-CR; n=13). Twelve months after the beginning of the feeding protocol, echocardiography and hemodynamic analysis were performed in all groups. Then, rats were euthanatized for histological and molecular analysis. An expanded Methods section appears in the Data Supplement.
In Vivo Experimental Procedures
MI, echocardiography, and hemodynamic analysis were performed as described.
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Plasma Membrane Levels of β-AR
Levels and Real-Time Polymerase Chain Reaction
Membrane proteins were isolated from LV samples 26 to evaluate protein levels of β 1 -adrenergic receptor (AR), β 2 -AR, and β 3 -AR. Real-time polymerase chain reaction was performed as described.
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Histological Sectioning and Staining
Masson trichrome staining was used to evaluate LV fibrosis while capillaries were detected by Lectin Bandeiraea simplicifolia I staining. Immunofluorescence technique was performed using antibodies against vesicular acetylcholine transporter and dopamine β-hydroxylase.
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Statistical Analysis
All values in the text and figures are presented as means±SEM. Statistical significance was determined by 1-or 2-way ANOVA with Bonferroni post hoc analysis or t test as appropriate. All data were analyzed using GraphPad-Prism software version 7. Probabilities of 0.05 or less were considered to be statistically significant.
RESULTS
Effect of Long-Term CR on Body Weight and Heart Weight
As expected, at 4 weeks post-surgery, before the start of dietary intervention, the average body weight (BW) was similar among all study groups ( Figure 1B ; Table) . Six months after the beginning of the CR diet protocol, average BW became significantly lower (P<0.001) in HF-CR rats compared with HF-ND rats ( Figure 1B ; Table) . Of note, at this time point, HF-ND BW was significantly higher compared with sham BW (P<0.05; Figure 1B ; Table) . Twelve months after the beginning of different dietary regimens, HF-CR rats showed a significantly lower BW compared with HF-ND and sham animals (respectively P<0.001 and P<0.0001) that was so evident on physical examination ( Figure 1B and 1C ). To analyze whether the different dietary protocols were able to influence the heart mass, we measured heart weight (HW), HW to tibia length (TL) ratio (HW/TL), and HW to BW ratio (HW/BW) at the end of the study period, in all groups. HW and HW/TL were significantly increased in HF-ND group compared with sham group, consistent with an HF phenotype (P<0.001), while HF-CR animals showed lower HW and HW/TL compared with HF-ND rats (P<0.01 and P<0.05, respectively; Figure 1D and 1E; Table) . As expected, HW/BW was increased in HF rats compared with sham (P<0.001 versus HF-ND, P<0.0001 versus HF-CR; Table) while HW/BW was not statistically different between HF-ND and HF-CR groups. Hence, we decided to analyze the correlation between HW and BW in all HF rats, and we found that there was a direct correlation between these parameters (R 2 =0.6546; P<0.0001), suggesting that the decrease in BW in rats treated with a restricted dietary regimen was paralleled by a proportional decrease in HW ( Figure 1F ). The latter observation could also explain the reason why we did not find any difference between HF-ND and HF-CR groups in terms of HW/BW ratio (Table) . Contrarily, HW/TL was significantly different between the 2 HF groups, as mentioned above, indicating that TL is not influenced by the dietetic regimen.
In Vivo Cardiac Function Over the Course of the Study Period and Biomarkers of HF
Four weeks after surgically induced MI, echocardiographic studies revealed that LV ejection fraction was significantly reduced in both groups of HF rats compared with sham while internal diameters at diastole and systole were significantly higher in HF rats compared with sham, which are expected post-MI findings (Figure 2A-2C ). At the same time point, cardiac function and structure, evaluated by echocardiography, were not different between the 2 HF groups, confirming a similar HF level between groups before the randomization to dietary interventions. Twelve months after the beginning of the CR or normal dietary programs in the HF rats, these groups still showed significantly impaired LV systolic function and increased LV diameters and volumes compared with sham rats (Figure 2D-2F; Table) . However, impairment in cardiac systolic function, as expressed by LV ejection fraction, and adverse LV remodeling, as measured by parameters of ventricular dilatation, further progressed in HF-ND rats (P<0.0001 versus sham at the end of the study), as observed by comparing measurements performed at 4 weeks post-MI induction to measures obtained at the end of the study period. Importantly, 12 months of a CR diet regimen resulted in blunted HF progression, Body weight (BW), heart weight (HW), HW/BW ratio, and HW/tibia length ratio (HW/TL), adrenal gland weight (AW), AW/BW ratio, and AW/TL ratio were measured in all groups. Left ventricular (LV) ejection fraction (EF), internal diameter at diastole (LVIDd) and systole (LVIDs), anterior wall in diastole (LVAWd) and systole (LVAWs), posterior wall in diastole (LVPWd) and systole (LVPWs), volume in systole (LVVol-s) and diastole (LVVol-d), and heart rate (HR) were evaluated in all groups. In vivo HR, LV +dP/dt, −dP/dt, end-diastolic pressure (EDP), and end-systolic pressure (ESP) were assessed under basal conditions and after maximal isoproterenol (ISO) stimulation (333 ng/kg BW). n=6 to 13. Data are presented as mean±SEM. One-way ANOVA and Bonferroni test were used between groups. CR indicates caloric restriction; HF, heart failure; and ND, normal diet. and in fact, HF-CR rats showed increased cardiac function and reduced LV diameters and volumes compared with HF-ND rats (Figure 2E and 2F; Table) .
At the end of the study period, LV catheterization and hemodynamic analysis showed a significant reduction in LV contractility and relaxation in HF-ND group compared with sham confirming HF-dependent cardiac dysfunction and adverse remodeling (Figure 3 ; Table) . Of note, HF-CR rats showed a significant decrease in LV relaxation index compared with sham animals (P<0.05) while +dP/dt was not different between HF-CR and sham. Importantly, on infusion of a maximal dose of isoprotenerol (333 ng/kg BW), rats undergoing CR showed a robust improvement of both LV contractility and relaxation compared with control diet HF rats. In fact, HF-CR group showed a significant increase in +dP/dt and a significant decreased in −dP/dt compared with HF-ND group (P<0.001 and P<0.05, respectively; Figure 3 ; Table) . This latter finding suggests that a chronic CR diet is able to improve inotropic reserve of the failing heart. Furthermore, we assessed cardiac expression of specific genes known to play a role in HF pathogenesis and progression. At this regard, we measured the mRNA levels of atrial natriuretic factor, β-myosin heavy chain, and endothelin-1 in the LV of all groups via real-time polymerase chain reaction ( Figure I in the Data Supplement). Consistent with functional and structural data (see below), atrial natriuretic factor and β-myosin heavy chain mRNA levels were markedly increased in HF-ND rats group compared with sham rats (P<0.05; Figure I in the Data Supplement). Interestingly, atrial natriuretic factor levels were significantly reduced in HF-CR rats to levels similar to sham animals (P<0.05; Figure I in the Data Supplement). In addition, we found a trend to increase in endothelin-1 mRNA levels in HF rats treated with CR diet when compared with HF-ND group ( Figure I in the Data Supplement).
Effects of CR on Cardiac β-AR Level and Adrenal Catecholamine Synthesis
Based on our in vivo findings, indicating that CR was able to ameliorate cardiac β-AR responsiveness in HF rats, we measured by Western blot β 1 -AR levels on plasma membranes isolated from the hearts of all groups. As expected, we observed a significant reduction in β 1 -AR plasma membrane levels in HF-ND hearts compared with sham hearts (P<0.05; Figure 4A and 4B). Importantly, 1 year of CR diet was able to completely prevent HF-related cardiac β 1 -AR downregulation. Indeed, when compared with HF-ND group, HF-CR hearts showed a significant increase in β 1 -AR plasma membrane density that was equivalent to that observed in sham hearts ( Figure 4A and 4B) . No differences were found in β 2 -AR and β 3 -AR membrane levels between sham, HF-ND, and HF-CR groups ( Figure II in the Data Supplement).
Moreover, we measured adrenal mRNA levels of enzymes involved in the production of catecholamines: tyrosine hydroxylase, DOPA (dihydroxyphenylalanine) decarboxylase, dopamine β-hydroxilase, and phenylethanolamine N-methyltransferase. We found that CR treatment was able to decrease HFrelated adrenal tyrosine hydroxylase upregulation to the levels observed in sham animals ( Figure III in the Data Supplement). In addition, there was a trend to decrease in adrenal mRNA levels of phenylethanolamine N-methyltransferase in the HF-CR group when compared with HF-ND group (Figure III in the Data Supplement). No differences were found between HF groups in adrenal DOPA decarboxylase and dopamine β-hydroxylase gene expression (Figure III in the Data Supplement). Accordingly, adrenal weight (AW) and AW/TL ratio were reduced in HF-CR rats to the levels observed in sham animals (Table; Figure III in the Data Supplement). No differences in AW/BW ratio have been found between the 3 study groups (Table) .
Effects of CR on Cardiac Fibrosis, Capillary Density, and Innervation
Masson trichrome staining was performed on cardiac specimens obtained from all study groups at the end of the study period. Interstitial fibrosis was measured in sham animals as well as in the remote area and border zone (BZ) of HF groups ( Figure 5A ). As indicated in Figure 5B , HF-ND rats showed a vast amount of fibrosis that was negligible in sham animals. Importantly, 12 months of a CR diet dramatically resulted in a robust reduction in cardiac fibrosis both in BZ and remote area, as evident by comparing HF-CR to HF-ND hearts (P<0.0001; Figure 5A and 5B). At a molecular level, we found that 1-year CR dietary treatment did not Moreover, we evaluated cardiac angiogenesis at the end of the study period and found that capillary density was significantly increased (P<0.01) in HF-CR hearts compared with HF-ND in the remote area ( Figure V in the Data Supplement). There was a trend to increase in capillary density of the BZ of HF-CR hearts when compared with the BZ of HF-ND (P=0.1452).
Furthermore, we evaluated adrenergic and cholinergic cardiac innervation by immunofluorescence in all study groups (Figure 6 ). HF-ND rats showed a significant decrease in both adrenergic and cholinergic nerves compared with sham animals (respectively P<0.05 and P<0.0001; Figure 6A and 6C). Remarkably, LV specimens from HF-CR animals revealed an enhancement in adrenergic innervation as suggested by dopamine β-hydroxylase staining (P<0.01) when compared with HF-ND group ( Figure 6A and 6C) . Of note, CR was not able to significantly affect cardiac cholinergic innervation.
DISCUSSION
In the present study, we have demonstrated that a longterm CR regimen in post-MI rats, started when HF was already established, is able to (1) improve HF-related maladaptive remodeling; (2) enhance cardiac function and inotropic reserve; (3) restore HF-related β 1 -AR downregulation; (4) reduce cardiac fibrosis; and (5) increase cardiac adrenergic innervation and capillary density.
Over the past decade, several preclinical and clinical studies have provided evidence indicating that CR is a safe and effective treatment for age-related cardiovascular diseases. 28 Importantly, it has been recently published that a 2-year long CR diet can positively influence quality of life, global health, mood, and sleep quality in healthy nonobese adults. 29 This latter finding is of particular interest because depression is known to negatively impact on morbidity and mortality of patients with HF. 30, 31 Importantly, restricted dietary regimens have been shown to exert cardioprotective effect as shown in several models of cardiac dysfunction, such as ischemia/reperfusion, MI, and LV hypertrophy. 4, 11, 17, 18, 28, [32] [33] [34] [35] [36] The molecular mechanisms underlying these beneficial effects include, but are not limited to, a reduction in cardiac free radical and reactive oxygen species production, a decrease in cardiac and systemic inflammation, an improvement in mitochondrial function, as well as an increase in adiponectin circulating levels and consequent activation of cardiac AMP-activated protein kinase-endothelial nitric oxide synthase signaling pathway. 20, 28, 33, 34, [36] [37] [38] [39] [40] However, whether CR can be an effective long-lasting treatment in chronic HF has not been studied, yet. This is of crucial importance because HF is a chronic disease, and current treatments are only effective at slowing disease progression. Ahmet et al 18 have investigated the short-term effects of CR in an ischemic model of HF (up to 10 weeks post-MI) and have found that a CR diet is associated only with a trend to decrease in the end-diastolic volume compared with controls. This latter finding may be explained by the fact that a dietetic treatment needs a longer period to exert its beneficial effects on cardiac structure and function. However, Katare et al 21 found that short-term IF regimen preserved cardiac volumes and improved LV function after MI. Interestingly, our study indicates that 1 year of CR diet is able to reduce both systolic and diastolic LV diameters, thus positively impacting on cardiac remodeling (Figure 2E and 2F ; Table) . Although, we are aware that a dietary regimen should be started as early as possible to prevent cardiovascular diseases or to slow their progression, it is recognized that, in the clinical practice, patients are motivated to start a dietetic treatment only when a debilitating chronic disease manifests itself. Therefore, we decided to randomize HF rats to ad libitum or CR diets 4 weeks post-MI, a time point where cardiac dysfunction is already established.
CR can be performed either through daily reduction of caloric intake (15%-60% less than ad libitum caloric intake without altering the levels of vitamins, minerals, and amino acids) or by IF through the alternation of a complete fasting day with a feed day. Recently, IF has been proposed also in humans to obtain a BW reduction because it seems to be easier to be followed and sometimes less frustrating than traditional CR dietary regimens, where subjects are not authorized to have a freely eating day. In particular, IF protocols proposed for humans consists in (1) restricting energy intake on 1 to 3 d/wk and eating liberally on the nonrestricted days; and (2) alternate day fasting regimen that includes a fast day (75% energy restriction) alternating with a ad libitum diet day. 7, 41 Of note, IF has been shown to induce a BW and fat mass reduction that was similar to those obtained with other CR diets. 41 Importantly, our study is the first indicating that a 12-month-long CR regimen is able to improve cardiac remodeling, as indicated by the decreased LV diameters/volumes and fibrosis observed in HF-CR compared with HF-ND rats. Moreover, our results indicate that the beneficial effects of CR on cardiac function are also evident on cardiac inotropic reserve, as indicated by the results of the in vivo hemodynamics after challenge with β-agonist isoproterenol. To confirm our results at molecular level, we have measured cardiac β 1 -AR membrane density in all study groups. β-AR dysfunctional signaling is recognized to be relevant pathogenic mechanisms in HF, and reduced β-AR responsiveness has been described in several models of HF, as well as, in patients with HF. [42] [43] [44] [45] Moreover, therapeutic intervention able to restore HFrelated cardiac β-AR abnormalities has been shown to be therapeutically effective. 44 In our study, HF control hearts show reduced β 1 -AR plasma membrane density, and, importantly, long-term CR is able to completely restore β 1 -AR downregulation at levels similar to those observed in sham hearts. CR did not affect plasma membrane levels of β 2 -AR and β 3 -AR in our postischemic HF model.
The adrenal medulla (the central part of the adrenal gland) is the major source of cathecolamine circulating levels. In fact, almost all circulating epinephrine levels together with a significant amount of circulating norepinephrine levels derive from the adrenal medulla. 43 In our study, 1-year CR reduced adrenal tyrosine hydroxylase levels as well as AW and AW/ TL ratio to the levels of the sham animals ( Figure III in the Data Supplement). These data are particularly interesting because the rate-limiting step in catecholamines' biosynthesis is the hydroxylation of l-tyrosine to l-DOPA mediated by tyrosine hydroxylase. 46 Given these results, we may speculate that CR diet might be able to blunt, at least in part, HF-related sympathetic nervous system hyperactivity.
Furthermore, in our study, long-term CR diet is associated with a reduction in cardiac fibrosis and increased capillary density ( Figure 5 ; Figure . This protective molecular mechanism can explain, at least in part, the tremendous decrease in fibrosis in the BZ of HF-CR rats compared with HF-ND rats. However, we cannot exclude that a dietary treatment is also able to blunt profibrosis mechanisms (like TGF-β pathway) in an early phase of the dietetic regimen.
Functional and structural data have been confirmed by CR-induced changes in HF biomarkers. Long-term dietary treatment was able to significantly reduce HFrelated upregulation of cardiac atrial natriuretic factor and to increase cardiac levels of endothelin-1. Importantly, even a modest reduction in endothelin-1 gene expression has been shown to decrease cardiac function. 48 Another pivotal characteristic of chronic HF is represented by cardiac sympathetic denervation that has been described both in preclinical models and in patients with HF, and it has been related to the high risk of sudden cardiac death because of ventricular arrhythmias, observed in patients with HF. 49 During HF, a dramatic loss in cardiac nerve fibers and, in particular, in sympathetic fibers has been described. 50, 51 This is due, at least in part, to cholinergic transdifferentiation of cardiac sympathetic nervous system cardiac nerve terminals. 52 As expected, we observed a dramatic loss of both cholinergic and adrenergic fibers in HF-ND rats compared with sham animals. More importantly, CR resulted in a significant increase in sympathetic cardiac nerve fibers as evident by comparing HF-CR to HF-ND hearts. This result is consistent with previous findings that showed neuroprotective effects of CR in models of neuronal damage or cognitive impairment. 53 Recently, a CR dietary program has been tested in obese older patients with clinically stable HF and preserved ejection fraction in a randomized clinical trial. 22 The authors found that CR was able to increase peak Vȯ 2 and to decrease LV mass, circulating C-reactive protein, and cholesterol levels. 22 This latter investigation is consistent with the results of the present study and open to the idea to test if CR could be effective also in patients with ischemic HF and whether this dietary intervention may have an additive effect when combined with aerobic exercise training.
From a clinical point of view, we can hypothesize that CR could be associated with other pharmacological medications used in HF, such as β-blockers and angiotensin-converting enzyme inhibitors. Long-term β-blocker treatment is associated with weight gain and new onset diabetes mellitus. 54, 55 Consequently, a restricted dietary program could, at least in part, counteract the metabolic side effects of β-blockade in patients with HF. However, the concomitant use of β-blocker and CR diet needs further investigation because Azar et al 56 have shown that obese individuals treated with β-blockers exhibit significant impairments in weight loss and waist circumference reduction in response to a hypocaloric dietary intervention.
Overall, the findings of the present study are of particular interest because dietary interventions represent a cost saving therapeutic modality, whose favorable properties seem to show effectiveness comparable to that obtained with pharmacological interventions currently used in the clinical practice.
Study Limitations
Because of the long-term nature of our study, it is difficult to obtain information on the mechanisms that are involved in the beneficial effects of CR in HF. In fact, the functional, molecular, and structural observations that we have found at the end of the study period (13-month post-MI) may be the result of molecular mechanisms acting at the initial phase of the dietetic regimen. Moreover, we recognize that the lack of a sham group fed with a CR diet could represent a limitation of the present study, but our interest was mainly focused on the long-term effects of CR in a postischemic model of HF, where altered β-AR signaling, increased cardiac fibrosis, and denervation represent relevant pathogenic mechanisms that are currently therapeutic targets to curb HF progression. At this regard, Ahmet et al 18 characterized the outcomes of different long-term diets (CR versus ad libitum) on cardiovascular fitness during aging. They showed positive effects of a long-lasting CR on LV diastolic function and remodeling in 24-month-old unoperated animals. Compared with ad libitum rats, 24-month-old CR rats showed reduced levels of cardiac fibrosis, attenuated diastolic dysfunction, but unchanged LV systolic function.
Conclusions
In summary, the present study reports that long-term CR, started when HF was already established, reverses cardiac dysfunction, attenuates LV remodeling, and improves cardiac inotropic reserve in an experimental model of postischemic HF. As a contributing mechanism, we found that CR diet significantly reduces cardiac fibrosis and improves sympathetic cardiac innervation and β-AR membrane density in HF. Importantly, the beneficial effects of CR are strongly effective after 12 months of this regimen, providing evidence that this therapeutic approach is applicable long term although started when cardiac dysfunction was already evident. The true clinical potential of CR for a place in the HF therapeutic armamentarium awaits clinical validation in patients.
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